Reika Iwakawa

发表

Comprehensive genomic profiles of small cell lung cancer

Martin Vingron, Jan O. Korbel, Lucia Anna Muscarella, 2015, Nature.

Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.

Satoru Miyano, Rui Yamaguchi, Seiichiro Yamamoto, 2012, Cancer research.

Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis

Hironobu Ohmatsu, Shingo Matsumoto, Akiko Takahashi, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma

J. Yokota, M. Noguchi, T. Iijima, 2014, Cancer science.

Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer

I. Petersen, J. Yokota, C. Harris, 2016, Clinical Cancer Research.

TSPAN2 is involved in cell invasion and motility during lung cancer progression.

J. Yokota, T. Kohno, T. Ochiya, 2014, Cell reports.

MYC Amplification as a Prognostic Marker of Early-Stage Lung Adenocarcinoma Identified by Whole Genome Copy Number Analysis

J. Yokota, T. Kohno, S. Ogawa, 2010, Clinical Cancer Research.

KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer.

F. Setién, M. Esteller, J. Yokota, 2015, Cancer research.

KAT 6 B Is a Tumor Suppressor Histone H 3 Lysine 23 Acetyltransferase UndergoingGenomic Loss in Small Cell Lung Cancer

F. Setién, M. Esteller, J. Yokota, 2015 .

KIF5B-RET fusions in lung adenocarcinoma

Yasushi Totoki, Koji Tsuta, Shun-ichi Watanabe, 2012, Nature Medicine.

Oncogenic Ras/ERK Signaling Activates CDCP1 to Promote Tumor Invasion and Metastasis

J. Yokota, R. Sakai, H. Tsuda, 2014, Molecular Cancer Research.

Oncogenes and Tumor Suppressors Oncogenic Ras / ERK Signaling Activates CDCP 1 to Promote Tumor Invasion and Metastasis

J. Yokota, R. Sakai, H. Tsuda, 2014 .

Whole genome comparison of allelic imbalance between noninvasive and invasive small-sized lung adenocarcinomas.

Shingo Matsumoto, Eiji Shimizu, Koji Tsuta, 2009, Cancer research.

Prevalence and specificity of LKB1 genetic alterations in lung cancers

J. Minna, J. Yokota, T. Kohno, 2007, Oncogene.

Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing.

N. Yanaihara, A. Okamoto, J. Yokota, 2015, International journal of oncology.

A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene

Luc Girard, Jun Yokota, Takashi Kohno, 2010, Genes, chromosomes & cancer.

Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer

J. Yokota, Y. Totoki, T. Kohno, 2013, Genes, chromosomes & cancer.

Frequent EGFR mutations in brain metastases of lung adenocarcinoma

J. Yokota, T. Kohno, R. Iwakawa, 2006, International journal of cancer.

HPV-associated lung cancers: an international pooled analysis.

F. Khuri, J. Yokota, D. Spandidos, 2014, Carcinogenesis.

Frequent EGFR mutations in noninvasive bronchioloalveolar carcinoma

Kenji Suzuki, J. Yokota, T. Kohno, 2006, International journal of cancer.

A gene‐alteration profile of human lung cancer cell lines

Jun Yokota, Ruben Pio, Takashi Kohno, 2009, Human mutation.

MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.

J. Yokota, T. Kohno, S. Moran, 2014, Cancer discovery.

Genomic Ampli fi cation of CD 274 ( PD-L 1 ) in Small-Cell Lung Cancer

I. Petersen, J. Yokota, C. Harris, 2017 .

Contribution of germline mutations to PARK2 gene inactivation in lung adenocarcinoma

J. Yokota, T. Kohno, S. Ogawa, 2012, Genes, chromosomes & cancer.

Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma

J. Yokota, T. Kohno, R. Iwakawa, 2010, Cancer science.

Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells.

J. Yokota, T. Kohno, T. Akiyama, 2010, Lung cancer.

Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon‐inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation

J. Yokota, T. Taki, M. Taniwaki, 2012, Cancer science.

Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.

S. Miyano, K. Kumamoto, J. Yokota, 2012, Cancer research.

Association of p16 Homozygous Deletions with Clinicopathologic Characteristics and EGFR/KRAS/p53 Mutations in Lung Adenocarcinoma

Kenji Suzuki, J. Yokota, T. Kohno, 2008, Clinical Cancer Research.

Expression and clinical significance of genes frequently mutated in small cell lung cancers defined by whole exome/RNA sequencing.

S. Miyano, J. Yokota, C. Harris, 2015, Carcinogenesis.

Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer.

Hakan Akca, Jun Yokota, J. Yokota, 2013, Cancer genetics.